These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36179954)

  • 1. Negative allosteric modulation of CB
    Iyer V; Rangel-Barajas C; Woodward TJ; Kulkarni A; Cantwell L; Crystal JD; Mackie K; Rebec GV; Thakur GA; Hohmann AG
    Pharmacol Res; 2022 Nov; 185():106474. PubMed ID: 36179954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative allosteric modulation of CB
    Iyer V; Saberi SA; Pacheco R; Sizemore EF; Stockman S; Kulkarni A; Cantwell L; Thakur GA; Hohmann AG
    Neuropharmacology; 2024 Oct; 257():110052. PubMed ID: 38936657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative allosteric modulation of cannabinoid CB
    Iyer V; Saberi SA; Pacheco R; Sizemore EF; Stockman S; Kulkarni A; Cantwell L; Thakur GA; Hohmann AG
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative allosteric modulation of CB1 cannabinoid receptor signalling decreases intravenous morphine self-administration and relapse in mice.
    Oliva I; Kazi F; Cantwell LN; Thakur GA; Crystal JD; Hohmann AG
    Addict Biol; 2024 Aug; 29(8):e13429. PubMed ID: 39109814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative allosteric modulation of CB1 cannabinoid receptor signaling decreases intravenous morphine self-administration and relapse in mice.
    Oliva I; Kazi F; Cantwell LN; Thakur GA; Crystal JD; Hohmann AG
    bioRxiv; 2024 Jan; ():. PubMed ID: 38293046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
    Slivicki RA; Xu Z; Kulkarni PM; Pertwee RG; Mackie K; Thakur GA; Hohmann AG
    Biol Psychiatry; 2018 Nov; 84(10):722-733. PubMed ID: 28823711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Allosteric Modulation of CB
    Slivicki RA; Iyer V; Mali SS; Garai S; Thakur GA; Crystal JD; Hohmann AG
    Front Mol Neurosci; 2020; 13():54. PubMed ID: 32410959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cannabinoid CB
    Iyer V; Slivicki RA; Thomaz AC; Crystal JD; Mackie K; Hohmann AG
    Eur J Pharmacol; 2020 Nov; 886():173544. PubMed ID: 32896549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bi-directional cannabinoid signalling in the basolateral amygdala controls rewarding and aversive emotional processing via functional regulation of the nucleus accumbens.
    Ahmad T; Sun N; Lyons D; Laviolette SR
    Addict Biol; 2017 Sep; 22(5):1218-1231. PubMed ID: 27230434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference.
    Karimi S; Azizi P; Shamsizadeh A; Haghparast A
    Behav Brain Res; 2013 Jun; 247():125-31. PubMed ID: 23523958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.
    Dodu JC; Moncayo RK; Damaj MI; Schlosburg JE; Akbarali HI; O'Brien LD; Kendall DA; Wu Z; Lu D; Lichtman AH
    J Pharmacol Exp Ther; 2022 Jan; 380(1):1-14. PubMed ID: 34625464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of CB1 receptors in the ventral tegmental area in the potentiation of morphine rewarding properties in acquisition but not expression in the conditioned place preference model.
    Rashidy-Pour A; Pahlevani P; Vaziri A; Shaigani P; Zarepour L; Vafaei AA; Haghparast A
    Behav Brain Res; 2013 Jun; 247():259-67. PubMed ID: 23511249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptors in the basolateral amygdala are involved in the potentiation of morphine rewarding properties in the acquisition, but not expression of conditioned place preference in rats.
    Haghparast A; Shamsizadeh A; Samandari R; Omranifard A; Vaziri A; Razavi Y
    Brain Res; 2014 May; 1565():28-36. PubMed ID: 24721524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus.
    Zhang J; Wang N; Chen B; Wang Y; He J; Cai X; Zhang H; Wei S; Li S
    Neurosci Lett; 2016 Sep; 630():70-76. PubMed ID: 27461790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects.
    Ignatowska-Jankowska BM; Baillie GL; Kinsey S; Crowe M; Ghosh S; Owens RA; Damaj IM; Poklis J; Wiley JL; Zanda M; Zanato C; Greig IR; Lichtman AH; Ross RA
    Neuropsychopharmacology; 2015 Dec; 40(13):2948-59. PubMed ID: 26052038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evaluation of the CB
    Mustafa M; Donvito G; Moncayo L; Swafford A; Poklis J; Grauer R; Olszewska T; Ignatowska-Jankowska B; Kendall DA; Lu D; Lichtman AH
    Pharmacol Biochem Behav; 2020 Mar; 190():172840. PubMed ID: 31899221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The In Vivo Effects of the CB
    Cairns EA; Szczesniak AM; Straiker AJ; Kulkarni PM; Pertwee RG; Thakur GA; Baldridge WH; Kelly MEM
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):582-590. PubMed ID: 28719234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid transmission in the prelimbic cortex bidirectionally controls opiate reward and aversion signaling through dissociable kappa versus μ-opiate receptor dependent mechanisms.
    Ahmad T; Lauzon NM; de Jaeger X; Laviolette SR
    J Neurosci; 2013 Sep; 33(39):15642-51. PubMed ID: 24068830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.
    Pacheco Dda F; Klein A; Perez AC; Pacheco CM; de Francischi JN; Reis GM; Duarte ID
    Br J Pharmacol; 2009 Sep; 158(1):225-31. PubMed ID: 19594755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulatory role of the intra-accumbal CB1 receptor in protein level of the c-fos and pCREB/CREB ratio in the nucleus accumbens and ventral tegmental area in extinction and morphine seeking in the rats.
    Khaleghzadeh-Ahangar H; Khodagholi F; Shaerzadeh F; Haghparast A
    Brain Res Bull; 2018 Sep; 142():320-327. PubMed ID: 30170186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.